{"id":176948,"date":"2022-08-16T09:06:25","date_gmt":"2022-08-16T09:06:25","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=176948"},"modified":"2022-08-16T09:06:25","modified_gmt":"2022-08-16T09:06:25","slug":"acquired-hypogammaglobulinemia","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/","title":{"rendered":"Acquired hypogammaglobulinemia"},"content":{"rendered":"<p>A form of hypogammaglobulinemia that usually appears between 15 and 35 years of age. Patients have total immunoglobulin levels of less than 300 mg\/dl, IgG levels of less than 250 mg\/dl, a propensity to infection, lymphadenopathy, and splenomegaly. The cause is unknown. Patients should not be vaccinated with live attenuated (weakened) vaccines because of the risk of infection from the injection. Treatment includes intravenous immune globulin (200-400 mg\/kg) each month and administration of specific antibiotics when needed for specific infections. Although patients often live normal life spans, chronic lung disease is a common complication and may cause an earlier than expected death.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A form of hypogammaglobulinemia that usually appears between 15 and 35 years of age. Patients have total immunoglobulin levels of less than 300 mg\/dl, IgG levels of less than 250 mg\/dl, a propensity to infection, lymphadenopathy, and splenomegaly. The cause is unknown. Patients should not be vaccinated with live attenuated (weakened) vaccines because of the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-176948","post","type-post","status-publish","format-standard","hentry","category-a"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Acquired hypogammaglobulinemia - Definition of Acquired hypogammaglobulinemia<\/title>\n<meta name=\"description\" content=\"A form of hypogammaglobulinemia that usually appears between 15 and 35 years of age. Patients have total immunoglobulin levels of less than 300 mg\/dl, IgG levels of less than 250 mg\/dl, a propensity to infection, lymphadenopathy, and splenomegaly. The cause is unknown. Patients should not be vaccinated with live attenuated (weakened) vaccines because of the risk of infection from the injection. Treatment includes intravenous immune globulin (200-400 mg\/kg) each month and administration of specific antibiotics when needed for specific infections. Although patients often live normal life spans, chronic lung disease is a common complication and may cause an earlier than expected death.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acquired hypogammaglobulinemia - Definition of Acquired hypogammaglobulinemia\" \/>\n<meta property=\"og:description\" content=\"A form of hypogammaglobulinemia that usually appears between 15 and 35 years of age. Patients have total immunoglobulin levels of less than 300 mg\/dl, IgG levels of less than 250 mg\/dl, a propensity to infection, lymphadenopathy, and splenomegaly. The cause is unknown. Patients should not be vaccinated with live attenuated (weakened) vaccines because of the risk of infection from the injection. Treatment includes intravenous immune globulin (200-400 mg\/kg) each month and administration of specific antibiotics when needed for specific infections. Although patients often live normal life spans, chronic lung disease is a common complication and may cause an earlier than expected death.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-16T09:06:25+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/\",\"name\":\"Acquired hypogammaglobulinemia - Definition of Acquired hypogammaglobulinemia\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-08-16T09:06:25+00:00\",\"dateModified\":\"2022-08-16T09:06:25+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A form of hypogammaglobulinemia that usually appears between 15 and 35 years of age. Patients have total immunoglobulin levels of less than 300 mg\/dl, IgG levels of less than 250 mg\/dl, a propensity to infection, lymphadenopathy, and splenomegaly. The cause is unknown. Patients should not be vaccinated with live attenuated (weakened) vaccines because of the risk of infection from the injection. Treatment includes intravenous immune globulin (200-400 mg\/kg) each month and administration of specific antibiotics when needed for specific infections. Although patients often live normal life spans, chronic lung disease is a common complication and may cause an earlier than expected death.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acquired hypogammaglobulinemia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acquired hypogammaglobulinemia - Definition of Acquired hypogammaglobulinemia","description":"A form of hypogammaglobulinemia that usually appears between 15 and 35 years of age. Patients have total immunoglobulin levels of less than 300 mg\/dl, IgG levels of less than 250 mg\/dl, a propensity to infection, lymphadenopathy, and splenomegaly. The cause is unknown. Patients should not be vaccinated with live attenuated (weakened) vaccines because of the risk of infection from the injection. Treatment includes intravenous immune globulin (200-400 mg\/kg) each month and administration of specific antibiotics when needed for specific infections. Although patients often live normal life spans, chronic lung disease is a common complication and may cause an earlier than expected death.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/","og_locale":"en_US","og_type":"article","og_title":"Acquired hypogammaglobulinemia - Definition of Acquired hypogammaglobulinemia","og_description":"A form of hypogammaglobulinemia that usually appears between 15 and 35 years of age. Patients have total immunoglobulin levels of less than 300 mg\/dl, IgG levels of less than 250 mg\/dl, a propensity to infection, lymphadenopathy, and splenomegaly. The cause is unknown. Patients should not be vaccinated with live attenuated (weakened) vaccines because of the risk of infection from the injection. Treatment includes intravenous immune globulin (200-400 mg\/kg) each month and administration of specific antibiotics when needed for specific infections. Although patients often live normal life spans, chronic lung disease is a common complication and may cause an earlier than expected death.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/","og_site_name":"Glossary","article_published_time":"2022-08-16T09:06:25+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/","name":"Acquired hypogammaglobulinemia - Definition of Acquired hypogammaglobulinemia","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-08-16T09:06:25+00:00","dateModified":"2022-08-16T09:06:25+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A form of hypogammaglobulinemia that usually appears between 15 and 35 years of age. Patients have total immunoglobulin levels of less than 300 mg\/dl, IgG levels of less than 250 mg\/dl, a propensity to infection, lymphadenopathy, and splenomegaly. The cause is unknown. Patients should not be vaccinated with live attenuated (weakened) vaccines because of the risk of infection from the injection. Treatment includes intravenous immune globulin (200-400 mg\/kg) each month and administration of specific antibiotics when needed for specific infections. Although patients often live normal life spans, chronic lung disease is a common complication and may cause an earlier than expected death.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/acquired-hypogammaglobulinemia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Acquired hypogammaglobulinemia"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/176948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=176948"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/176948\/revisions"}],"predecessor-version":[{"id":176949,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/176948\/revisions\/176949"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=176948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=176948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=176948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}